SAGA Metals Corp. announced new assay results from its 2026 drilling program at the Radar Titanium-Vanadium-Iron Project in Labrador, Canada. The latest drill holes showed consistent, broad intercepts of oxide mineralization with high grades of iron (Fe2O3 up to 58.33%), titanium (TiO2 up to 8.78%), and vanadium (V2O5 up to 0.459%). These results reinforce the potential for a large mineral resource, supporting the upcoming maiden Mineral Resource Estimate. The project benefits from strong infrastructure and is positioned to supply critical minerals for North American markets.
The European Medicines Agency's CHMP has recommended approving Johnson & Johnson's TALVEY® (talquetamab) combined with daratumumab for treating relapsed or refractory multiple myeloma earlier in the treatment process, starting from the second line. T...
The European Medicines Agency's CHMP has recommended approval for Johnson & Johnson's TALVEY® (talquetamab) in combination with daratumumab for treating relapsed or refractory multiple myeloma (RRMM) in patients who have had at least one prior therap...
Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...
Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...
